{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:34:06Z","timestamp":1744202046362},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.lfs.2016.04.012","type":"journal-article","created":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T02:16:42Z","timestamp":1460341002000},"page":"75-78","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Treatment of membranous nephropathy with mizoribine: A control trial"],"prefix":"10.1016","volume":"154","author":[{"given":"Xichao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangke","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2016.04.012_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2016.04.012_bb0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5414\/CN107500","article-title":"Maintenance therapy with single-daily, high-dose mizoribine after cyclophosphamide therapy for prepubertal boys with severe steroid-dependent nephrotic syndrome","volume":"78","author":"Fujinaga","year":"2012","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.lfs.2016.04.012_bb0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00467-010-1707-7","article-title":"Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration","volume":"26","author":"Fujinaga","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.lfs.2016.04.012_bb0020","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s00467-011-1948-0","article-title":"Cyclophosphamide followed by mizoribine as maintenance therapy against refractory steroid-dependent nephrotic syndrome","volume":"26","author":"Ito","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.lfs.2016.04.012_bb0025","doi-asserted-by":"crossref","first-page":"681482","DOI":"10.1155\/2009\/681482","article-title":"Mizoribine: a new approach in the treatment of renal disease","volume":"2009","author":"Kawasaki","year":"2009","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.lfs.2016.04.012_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10157-004-0276-0","article-title":"A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey)","volume":"8","author":"Shibasaki","year":"2004","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.lfs.2016.04.012_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/bbrc.2000.3104","article-title":"Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein","volume":"274","author":"Takahashi","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2016.04.012_bb0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1523-1755.2000.00168.x","article-title":"A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome","volume":"58","author":"Yoshioka","year":"2000","journal-title":"Kidney Int."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516302338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516302338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T08:56:24Z","timestamp":1536828984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516302338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":8,"alternative-id":["S0024320516302338"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.04.012","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of membranous nephropathy with mizoribine: A control trial","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}